Ticker > Company >

Alembic share price

Alembic Ltd.

NSE: ALEMBICLTD BSE: 506235 SECTOR: Pharmaceuticals & Drugs  1.08 L   317   64

111.85
-2.35 (-2.06%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 113.2

Today's Low

₹ 111.65

52 Week High

₹ 169

52 Week Low

₹ 85.55

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

2872.1 Cr.

Enterprise Value

2882.36 Cr.

No. of Shares

25.68 Cr.

P/E

20.23

P/B

3.37

Face Value

₹ 2

Div. Yield

2.15 %

Book Value (TTM)

₹  33.23

CASH

4.19 Cr.

DEBT

14.45 Cr.

Promoter Holding

70.88 %

EPS (TTM)

₹  5.53

Sales Growth

40.79%

ROE

17.08 %

ROCE

18.25%

Profit Growth

52.82 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year40.79%
3 Year41.31%
5 Year23.81%

Profit Growth

1 Year52.82%
3 Year18.31%
5 Year8.7%

ROE%

1 Year17.08%
3 Year12.34%
5 Year9.68%

ROCE %

1 Year18.25%
3 Year13.35%
5 Year10.64%

Debt/Equity

0.0169

Price to Cash Flow

35.44

Interest Cover Ratio

84.0632

CFO/PAT (5 Yr. Avg.)

0.285784472345378

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 70.88 0.00
Mar 2025 70.88 0.00
Dec 2024 70.88 0.00
Sep 2024 70.88 0.00
Jun 2024 70.88 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 18.3106221807773% for the Past 3 years.
  • The company has shown a good revenue growth of 41.3054628889372% for the Past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 84.0632.
  • The Company has been maintaining an effective average operating margins of 28.1068107250428% in the last 5 years.
  • Company’s PEG ratio is 0.3831034468319.
  • The company has an efficient Cash Conversion Cycle of 49.0158 days.
  • The company has a high promoter holding of 70.88%.

 Limitations

  • Tax rate is low at 6.607.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 47.51 49.08 51.1 55.97 58.22
Total Expenditure 24.14 29.63 32.72 30.25 32.21
Operating Profit 23.37 19.45 18.38 25.72 26.01
Other Income 1.95 1.89 65.59 4.24 2.78
Interest 0.33 0.34 0.51 0.52 0.45
Depreciation 1.38 2.41 2.59 2.59 2.66
Exceptional Items 0 0 0 0 0
Profit Before Tax 23.61 18.59 80.87 26.85 25.68
Tax 2.93 1.75 4.27 1.16 2.85
Profit After Tax 20.68 16.84 76.6 25.69 22.83
Adjusted EPS (Rs) 0.81 0.66 2.98 1 0.89

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 72.3 75.97 123.16 152.25 214.36
Total Expenditure 62.21 63.06 85.15 96 124.8
Operating Profit 10.09 12.92 38.01 56.25 89.55
Other Income 10.61 89.09 64.11 54.62 74.51
Interest 0.27 0.23 0.16 0.69 1.83
Depreciation 3.91 4.5 6.36 7.46 10.24
Exceptional Items 0 0 -10.61 0 0
Profit Before Tax 16.52 97.28 85 102.72 151.99
Tax 3.15 11.56 5.73 9.83 10.04
Net Profit 13.36 85.71 79.27 92.89 141.95
Adjusted EPS (Rs.) 0.52 3.34 3.09 3.62 5.53

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 51.36 51.36 51.36 51.36 51.36
Total Reserves 775.46 962.49 777.63 757.4 801.83
Borrowings 0 0 0 7.39 10.67
Other N/C liabilities 51.24 63.45 38.12 40.54 37.69
Current liabilities 58.39 66.89 86.95 94.71 124.35
Total Liabilities 936.45 1144.19 954.06 951.4 1025.9
Assets
Net Block 133.69 133.5 131.83 130.54 135.33
Capital WIP 37.27 0.19 0.13 1.1 0
Intangible WIP 0 0 0 0 0
Investments 565.5 702.38 461.07 399.78 364.11
Loans & Advances 0.85 4.98 0 35 35
Other N/C Assets 99.53 162.9 187.96 245.94 279.09
Current Assets 99.62 140.23 173.07 139.05 212.38
Total Assets 936.45 1144.19 954.06 951.4 1025.9
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 16.52 97.28 85 102.72 151.99
Adjustment 1.54 -79.16 -53.46 -42.82 -53.74
Changes in Assets & Liabilities -17.22 -31.35 9.59 -36.22 -2.71
Tax Paid -1.95 -8.64 -6.43 1.65 -14.51
Operating Cash Flow -1.12 -21.87 34.7 25.33 81.03
Investing Cash Flow -35.15 22.66 11.29 22.6 -21.79
Financing Cash Flow -15.27 -5.66 -46.08 -47.77 -57.7
Net Cash Flow -51.53 -4.86 -0.09 0.16 1.54

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 70.88 70.88 70.88 70.88 70.88
chirayu ramanbhai amin 3.24 3.24 3.24 3.24 3.24
inaaya shaunak amin 0.02 0.02 0.02 0.02 0.02
malika chirayu amin 2.99 2.99 2.99 2.99 2.99
naintara shaunak amin 0.02 0.02 0.02 0.02 0.02
nirayu limited 63.06 63.06 63.06 63.06 63.06
pranav chirayu amin 0.75 0.75 0.75 0.75 0.75
ranvir pranav amin 0.02 0.02 0.02 0.02 0.02
samira pranav amin 0.02 0.02 0.02 0.02 0.02
shaunak chirayu amin 0.75 0.75 0.75 0.75 0.75
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 29.12 29.12 29.12 29.12 29.12
investor education and pr... 1.20 1.25 - 1.27 1.27
llp 0.04 0.06 0.05 0.06 0.05
investor education and pr... - - 1.29 - -

Annual Reports

Title Link
Title Link
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit ICRA
Credit ICRA
Credit ICRA
Credit ICRA
TYPE AGENCY Link
TYPE AGENCY Link
Research BOB Capital Market

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Alembic Stock Price Analysis and Quick Research Report. Is Alembic an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Alembic and its performance over the period of time. Alembic stock price today is Rs 112.12.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Alembic cash from the operating activity was Rs 81.0345 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Alembic has a Debt to Equity ratio of 0.0169 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Alembic , the EPS growth was 52.8142 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Alembic has OPM of 41.7774199131453 % which is a good sign for profitability.
     
  • ROE: Alembic have a average ROE of 17.082 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Alembic is Rs 112.12. One can use valuation calculators of ticker to know if Alembic share price is undervalued or overvalued.
Last Updated on:
Brief about Alembic
X